Quantimak 600 600 mg Fim-coated tablets
PDF Leaflet Revision Date: July 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of Schistosomiasis caused by S. haematobium and S. mansoni.
Dosage (summary)
40 mg/kg body mass once or 20 mg/kg twice on a single day.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established for pregnancy; breastfeeding should be discontinued for treatment duration and 24 hours after.
Key Drug Interactions
- Strong inducers of Cytochrome P450 (e.g., rifampicin)
- Chloroquine
- Grapefruit juice
Contraindications
- Hypersensitivity to praziquantel
- First trimester of pregnancy
- Ocular cysticercosis
Common side effects
- Headache
- Dizziness
- Nausea
- Vomiting
- Allergic reactions
Counselling Points
- Take with liquid during or after meals
- Avoid driving or operating machinery on treatment day
Serious warnings
- Monitor patients with cardiac irregularities
- Caution in CNS pathology
Important Disclaimer
The Quantimak 600 600 mg Fim-coated tablets professional information leaflet below is the property of Macleods Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
